A Certified Reference Material
Features
  • This product is qualified as a Certified Reference Material (CRM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO 17034 international standards
  • This CRM has been characterized by metrologically valid procedures and may be used as a quantitative analytical reference standard
  • Certificate of analysis provides the certified property values and the associated uncertainties, including a statement of metrological traceability for the certified values
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • Bulk material is available for qualified institutions; please contact our sales department for pricing
  • Customers requiring an alternate batch of this product should purchase 9(R)-Δ6a,10a-THC (Alt. Batch CRM) (Item No. 42629)
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

9(R)-Δ6a,10a-THC (CRM)

A 1 mg/ml solution in acetonitrile

Item No. 33013

Exempt Product (US)
Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • 9(R)-Δ6a,10a-Tetrahydrocannabinol
  • 1(R)-Δ3-THC
Technical Information
Formal Name
(R)-7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
CAS Number
95720-01-7
Molecular Formula
C21H30O2
Formula Weight
314.5
Formulation
A 1 mg/ml solution in acetonitrile
SMILES
CC(C)(OC1=C2C(O)=CC(CCCCC)=C1)C3=C2C[C@H](C)CC3
InChi Code
InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h12-14,22H,5-11H2,1-4H3/t14-/m1/s1
InChi Key
NEBZNJDFIPBXCS-CQSZACIVSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $205

    Add
    Cayman Chemical
    Forensic Lab Guide Wall Posters

    Discover our collection of drug identification, naming, and metabolism posters for your lab. We offer all of our posters at no cost to help support the forensic community.

    REQUEST YOURS
    Product Description

    9(R)-Δ6a,10a-THC (CRM) (Item No. 33013) is a certified reference material that is structurally similar to known phytocannabinoids. It has been found as a byproduct in Cannabis processing and is a potential impurity or degradant in preparations of Δ9-THC.1,2 9(R)-Δ6a,10a-THC is regulated as a Schedule I compound in the United States. 9(R)-Δ6a,10a-THC (CRM) (Item No. 33013) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. Customers requiring an alternate batch of this product should purchase 9(R)-Δ6a,10a-THC (Alt. Batch CRM) (Item No. 42629).

    For more information, please see Cayman's Δ9-THC, Δ10-THC, and Δ6a,10a-THC metabolism monograph.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Hanuš, L.O., Meyer, S.M., Muñoz, E., et al. Phytocannabinoids: A unified critical inventory. Nat. Prod. Rep. 33(12), 1357-1392 (2016).

    2. Rosati, O., Messina, F., Pelosi, A., et al. One-pot heterogeneous synthesis of Δ3-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB1 and CB2 receptors. Eur. J. Med. Chem. 85, 77-86 (2014).

    Product Citations

    Chan-Hosokawa, A., Nguyen, L., Lattanzio, N., et al. Emergence of delta-8 tetrahydrocannabinol (THC) in DUID investigation casework: Method development, validation and application. J. Anal. Toxicol. bkab029 (2021).